Walleye Capital LLC Paratek Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $23,520 - $35,160	12,000 New	12,000 $31,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $191,374 - $294,798	-40,718 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $277,289 - $445,047	40,718 New	40,718 $278,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $48,548 - $75,684	-10,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $44,414 - $70,914	10,600 New	10,600 $57,000
Q3 2019 Nov 14, 2019	SELL	$3.08 - $5.76 $112,900 - $211,138	-36,656 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $127,196 - $231,665	36,656 New	36,656 $146,000
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $53,600 - $72,400	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $90,500 - $109,500	10,000 New	10,000 $97,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.